飛尚無煙煤(01738.HK)附屬就煤業機器及設備訂立融資租賃協議
飛尚無煙煤(01738.HK)公佈,其間接全資附屬貴州浦鑫及間接擁有大部分權益之附屬貴州永福,與中煤科工訂立融資租賃協議。據此,中煤科工同意按照貴州浦鑫及貴州永福作出之指示購買有關煤業機器及設備,其後出租予貴州浦鑫及貴州永福,租金總額3,326.22萬元人民幣(約4,070.63萬港元),爲期36個月。
此外,中煤科工同意按照貴州浦鑫及貴州永福作出之指示,向中煤科工(上海)及北京禾滿購買有關煤業機器及設備,總代價爲3,010.77萬元人民幣(約3,684.58萬港元)。
貴州永福委聘中煤科工提供有關融資租賃安排之若幹顧問服務,服務費爲135.48萬元人民幣(約165.81萬港元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.